2025 JUN CCSS S02: Multidrug-Resistant Organisms – Threats and Prevention Strategies

June 5, 2025

Target Audience

TBA

Learning Objectives

  1. Define multidrug-resistant (MDR) bacteria and its growing threat to healthcare.
  2. Explain the mechanisms by which bacteria develop resistance to antibiotics.
  3. Identify common MDR pathogens and associated healthcare-associated infections (HAIs).
  4. Discuss the factors contributing to the emergence of MDR bacteria.
  5. Describe strategies for preventing the spread of MDR bacteria in healthcare settings, including Infection Prevention and Control (IPC) and antibiotic/diagnostic stewardship efforts.
  6. Evaluate how the Multidrug-Resistant Organism Repository and Surveillance Network’s (MRSN’s) analysis and tools can collaborate with local IPCs for MDR control.
Course summary
Available credit: 
  • 1.00 ACCME Non-Physician CME Credit
    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 1.00 hours for completing this Course activity.
  • 1.00 Physicians (ACCME)

    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DHA, J-7, CEPO designated this Course for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
  • 1.00 Interprofessional Continuing Education (IPCE)

    In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

Course opens: 
05/05/2025
Course expires: 
06/19/2025
Event starts: 
06/05/2025 - 9:25am EDT
Event ends: 
06/05/2025 - 10:25am EDT
Part of: 
2025 JUN CCSS: Evidence-Based Approaches for Advancing Excellence in Primary Care
Add to calendar: 

MS Teams Link: TBA

Disclosure: 
Presenter is a stock shareholder with the following companies: Alnylam Pharmaceuticals, Armata Pharmaceuticals, Arrowhead Pharmaceuticals, Beam Therapeutics, CRISR Therapeutics, CVS Health, GSK, Ionis Pharmaceuticals, Moderna Inc, Pfizer Inc, Prime Medicine Inc, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals.
All relevant financial relationships have been resolved.

DHA J-7 staff, planners, authors, and content reviewers for this educational activity have no relevant financial relationship(s) with ineligible companies to disclose.

Speaker(s)

Army Major Benjamin Custer, MD, MPH&TM

has no relevant financial relationships to disclose at this time.

TBA

Available Credit

  • 1.00 ACCME Non-Physician CME Credit
    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 1.00 hours for completing this Course activity.
  • 1.00 Physicians (ACCME)

    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DHA, J-7, CEPO designated this Course for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
  • 1.00 Interprofessional Continuing Education (IPCE)

    In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

Please login or create an account to take this course.



Requirements: CE/CME certificates are awarded to participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest. The deadline to claim credit is Jun 19, 2025.

Access Code: Some activities require an access code to register or claim credit. Please contact the organization providing the activity for the access code. The Continuing Education Program Office (CEPO) does not provide access codes.

Accommodations: Please contact the course instructor to inquire about accommodations. For additional technical support, email [email protected].